Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 36Breast Neoplasms 32Rectal Neoplasms 25Esophageal Neoplasms 21Uterine Cervical Neoplasms 20Head and Neck Neoplasms 20Central Nervous System Neoplasms 19Lung Neoplasms 18Prostatic Neoplasms 17Lymphoma 17Esophageal Squamous Cell Carcinoma 17Leukemia 16Glioblastoma 16Squamous Cell Carcinoma of Head and Neck 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Carcinoma, Hepatocellular 12Sarcoma 10Neuroblastoma 10Neoplasms 10Nasopharyngeal Carcinoma 10Brain Neoplasms 10Astrocytoma 10Colorectal Neoplasms 9Pancreatic Neoplasms 7Glioma 7Neoplasm Metastasis 6Nasopharyngeal Neoplasms 6Lymphoma, Non-Hodgkin 6Stomach Neoplasms 5Recurrence 5

Interventions

Radiotherapy 1Pharmaceutical Preparations 1HMPL-013 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colorectal Adenocarcinoma × Radiotherapy × Clear all
NCT05635149 2022-12-02

Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Unknown
100 enrolled
Gastrointestinal

Colorectal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡